Lewy lean is caused by a combination of brain pathway dysfunction, impaired sensory processing, and sometimes medication side effects. The term describes a persistent, involuntary leaning of the trunk to one side, clinically known as Pisa syndrome. It affects roughly 15% of people with dementia with Lewy bodies and 7 to 10% of those with Parkinson’s disease. The lean appears or worsens when standing or walking but often improves when lying down.
How the Brain Loses Postural Control
Staying upright requires a surprisingly complex network. Your brain constantly integrates signals from your eyes, inner ear, and body position sensors, then coordinates the trunk muscles that keep you balanced. This loop runs through the cortex, basal ganglia, and brainstem. In Lewy body conditions, abnormal protein deposits disrupt multiple points in that network simultaneously.
The nigrostriatal pathway, which carries dopamine between deep brain structures involved in movement, is one of the primary systems affected. Dopamine is also a key modulator of the vestibular nuclei, the brainstem structures that process balance signals from the inner ear. When dopamine levels drop, both movement coordination and balance processing deteriorate at the same time. Studies using vestibular nerve testing show that the severity of balance pathway damage is measurably worse in people who develop the lean compared to those with Parkinson’s who don’t.
There’s also a strong cognitive component. Research published in Frontiers in Aging Neuroscience found that Lewy lean in dementia with Lewy bodies is specifically associated with deficits in attention, visuospatial processing, and executive function. People with the lean tend to misjudge their own trunk position, essentially losing the ability to sense that they’re tilted. The severity of this “trunk misperception” correlates directly with the degree of visuospatial impairment. In other words, the brain can no longer accurately map the body’s position in space, and the person has no awareness that they’re leaning.
Medications That Trigger or Worsen the Lean
Not all cases of Lewy lean come from disease progression alone. Certain medications can trigger or intensify the lateral tilt, sometimes within days or weeks of starting a new drug. This drug-induced form tends to appear subacutely and can worsen rapidly over a few months.
Antipsychotic medications are among the most common culprits, which is particularly relevant because people with Lewy body dementia are already highly sensitive to these drugs. Cholinesterase inhibitors, the class of medications most frequently prescribed to manage cognitive symptoms in dementia, have also been linked to Pisa syndrome. Case reports document the lean appearing after switching between different cholinesterase inhibitors, and pharmacovigilance studies have flagged the association more broadly.
The important distinction is that drug-induced lean, especially with recent onset, is often at least partially reversible. Adjusting or discontinuing the triggering medication can improve the tilt, and anticholinergic treatments have shown benefit in these cases. Chronic forms tied to long-term disease progression are less responsive to medication changes and more likely to involve structural changes in the muscles and spine over time.
Why It Leans to One Side
Lewy body conditions typically affect the two sides of the brain unevenly. The side with greater dopamine loss or more extensive protein deposits tends to produce weaker signaling to the trunk muscles on the opposite side, creating an asymmetric pull. The vestibulospinal pathway, which runs from the inner ear balance organs down through the brainstem to the spinal cord, also shows bilateral but uneven damage. This asymmetry is what produces a consistent lean in one direction rather than general unsteadiness.
People with Lewy lean also tend to veer while walking, drifting in the direction of the tilt. This veering gait has been specifically correlated with visual-perceptual impairment, reinforcing the idea that the lean isn’t purely a muscle or movement problem. It reflects a deeper failure of the brain’s spatial orientation system.
How It’s Identified
There are no universally agreed-upon diagnostic criteria, but most clinicians and researchers use a threshold of at least 10 degrees of lateral trunk flexion. The hallmark feature is that the lean worsens with standing or walking and reduces with passive mobilization or lying flat. This distinguishes it from fixed spinal deformities, which don’t change with position.
The lean often coexists with more severe neuropsychiatric symptoms, including hallucinations, agitation, and mood disturbances. In the context of Lewy body dementia, the appearance of Pisa syndrome generally signals more advanced or widespread brain involvement.
Impact on Daily Life
Lewy lean is not just a cosmetic issue. The persistent trunk tilt shifts the body’s center of gravity, significantly increasing fall risk. Low back pain is common because the muscles on the shortened side of the trunk stay chronically contracted while the opposite side is overstretched. Over time, this can lead to secondary changes in the spine and ribcage.
Quality of life drops measurably. Balance problems make independent walking risky, and the veering gait makes navigating doorways, hallways, and crowded spaces harder. Many people become more dependent on walkers or wheelchairs earlier than they otherwise would. The combination of physical instability and the cognitive deficits that accompany the lean creates a compounding effect on overall disability.
Treatment Options
Managing Lewy lean typically involves a combination of approaches rather than a single fix. The first step is reviewing all current medications to identify potential drug-induced causes. If the lean appeared after starting or changing a medication, adjusting that drug is the most direct intervention.
Physical rehabilitation focused on trunk strength, posture, and mobility is the standard non-drug approach. Intensive programs lasting around four weeks have been shown to improve axial posture and trunk mobility, though the gains tend to fade within four to six months without ongoing work.
Botulinum toxin injections into the overactive trunk muscles on the side of the lean have shown promise as a complement to rehabilitation. In a placebo-controlled study, patients who received the injections before starting a four-week intensive rehab program showed better improvement in posture, trunk mobility, and pain control compared to those who received rehab alone. The injections appear to relax the chronically contracted muscles enough to let the rehabilitation exercises work more effectively.
For the underlying disease-related causes, optimizing dopamine-based treatments can sometimes reduce the lean’s severity, though results vary. The multifactorial nature of the problem, involving dopamine loss, vestibular damage, and cognitive-spatial deficits all at once, means that targeting just one mechanism rarely resolves the lean completely.